Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03861793
Title A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine (ALKS 4230) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Patients With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Alkermes, Inc.
Indications

Advanced Solid Tumor

Therapies

ALKS 4230 + Pembrolizumab

ALKS 4230

Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Alkermes Investigational Site Recruiting Los Angeles California 90025 United States Details
Alkermes Investigational Site Recruiting Los Angeles California 90211 United States Details
Alkermes Investigational Site Recruiting Washington District of Columbia 20007 United States Details
Alkermes Investigational Site Recruiting Atlanta Georgia 30322 United States Details
Alkermes Investigational Site Recruiting Chicago Illinois 60612 United States Details
Alkermes Investigational Site Recruiting Bethesda Maryland 20817 United States Details
Alkermes Investigational Site Recruiting Detroit Michigan 48201 United States Details
Alkermes Investigational Site Recruiting Saint Paul Minnesota 55101 United States Details
Alkermes Investigational Site Recruiting Morristown New Jersey 07962 United States Details
Alkermes Investigational Site Recruiting Buffalo New York 14263 United States Details
Alkermes Investigational Site Recruiting Huntersville North Carolina 28078 United States Details
Alkermes Investigational Site Recruiting Cincinnati Ohio 45229 United States Details
Alkermes Investigational Site Recruiting Philadelphia Pennsylvania 19111 United States Details
Alkermes Investigational Site Recruiting Charleston South Carolina 29425 United States Details
Alkermes Investigational Site Withdrawn Austin Texas 78705 United States Details
Alkermes Investigational Site Recruiting Houston Texas 77030 United States Details
Alkermes Investigational Site Recruiting Salt Lake City Utah 84119 United States Details
Alkermes Investigational Site Recruiting Milwaukee Wisconsin 53226 United States Details
Alkermes Investigational Site Recruiting Edmonton Alberta T6G 1Z2 Canada Details
Alkermes Investigational Site Recruiting Hamilton Ontario L8V 5C2 Canada Details
Alkermes Investigational Sites Recruiting Montréal Quebec H2X 0C1 Canada Details
Alkermes Investigational Site Recruiting Montréal Quebec H3A 3J1 Canada Details
Alkermes Investigational Site Recruiting Montréal Quebec H3T 1E2 Canada Details
Alkermes Investigational Site Recruiting Québec Quebec G1R 2J6 Canada Details
National Cancer Center Not yet recruiting Goyang 10408 Korea, Republic of Details
Inha University Hospital Recruiting Incheon 22332 Korea, Republic of Details
Seoul National University Bundang Hospital Not yet recruiting Seongnam 13620 Korea, Republic of Details
Seoul National University Hospital Recruiting Seoul 03080 Korea, Republic of Details
Yonsei University Health System - Severance Hospital Recruiting Seoul 03722 Korea, Republic of Details
Asan Medical Center Recruiting Seoul 05505 Korea, Republic of Details
Samsung Medical Center Recruiting Seoul 6351 Korea, Republic of Details
The Catholic University of Korea St. Vincent's Hospital Recruiting Suwon 16247 Korea, Republic of Details
Alkermes Investigational Site Recruiting Rotterdam 3000 CA Netherlands Details
Alkermes Investigational Site Recruiting Utrecht 3508 GA Netherlands Details
Alkermes Investigational Site Recruiting Badalona 08916 Spain Details
Alkermes Investigational Site Recruiting Córdoba 14004 Spain Details
Alkermes Investigational Site Recruiting Madrid 28007 Spain Details
Alkermes Investigational Site Recruiting Madrid 28040 Spain Details
Alkermes Investigational Site Recruiting Madrid 28041 Spain Details
Alkermes Investigational Site Recruiting Madrid 28050 Spain Details
Alkermes Investigational Site Recruiting Madrid 28222 Spain Details
Alkermes Investigational Site Recruiting Málaga 29010 Spain Details
Alkermes Investigational Site Recruiting Valencia 46010 Spain Details
Alkermes Investigational Site Not yet recruiting Kaohsiung 83301 Taiwan Details
Alkermes Investigational Site Recruiting Taichung 40447 Taiwan Details
Alkermes Investigational Site Recruiting Tainan 704 Taiwan Details
Alkermes Investigational Site Not yet recruiting Taipei 100 Taiwan Details
Alkermes Investigational Site Recruiting Taipei 11217 Taiwan Details
Alkermes Investigational Site Recruiting Taipei 11259 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field